8-K Filing

Company

SAB Biotherapeutics, Inc.

Filed

January 10, 2022

Period of Report

January 7, 2022

Accession Number

0001493152-22-000737

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →